| Characteristics | Sub-Characteristic | Number of Patients/values | Percentage | |
| Age | <40 years old | 70 | 8.75% | |
| 40 - 59 | 15 | 18.75% | ||
| 60 - 69 | 18 | 22.5% | ||
| ≥70 | 40 | 50% | ||
| Gender | Male | 38 | 47.5% | |
| Female | 42 | 52.5% | ||
| Height | Mean of height (±SD) | 155.4 cm (±18.94) | - | |
| Height was not documented | 6 | 7.5% | ||
| Weight | Mean of weight (±SD) | 71.4 kg (±25.42) | - | |
| Weight was not documented | 3 | 3.75% | ||
| BMIa | BMI ≤ 18 | 10 | 12.5% | |
| BMI 18.5 - 25 | 22 | 27.5% | ||
| BMI 26 - 29 | 16 | 20% | ||
| BMI ≥ 30 | 19 | 23.75% | ||
| BMI > 40 | 8 | 10% | ||
| BMI not documented | 5 | 6.25% | ||
| Renal function Creatinine clearance (CrCl) | CrCl > 30 ml/ minute | 67 | 83.75% | |
| CrCl < 30 ml/ minutes | 7 | 8.75% | ||
| Dialysis | 4 | 5% | ||
| CrCl was not possible to calculate | 2 | 2.5% | ||
| Hepatic function (acute/ chronic) | Presence of hepatic dysfunction | 3 | 3.75% | |
| Absence of hepatic dysfunction | 77 | 96.25% | ||
| Thrombophilic condition | Cancer | 8 | 10% | |
| Hormonal Therapy | 1 | 1.25% | ||
| Obesity | 16 | 20% | ||
| Ulcerative colitis | 1 | 1.25% | ||
| Inflammatory bowel disease | 1 | 1.25% | ||
| Pregnancy | 1 | 1.25% | ||
| Medications that increase bleeding risk | Aspirin only | 27 | 33.75% | |
| Clopidogrel only | 6 | 7.5% | ||
| Aspirin and clopidogrel | 10 | 12.5% | ||
| None | 37 | 46.25% | ||